Although the outlook on AI is widely positive, not all equities in the space are poised for success, as several headwinds ...

Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Tenable Holdings is cheap compared to peers, with a potential upside of 24% based on price targets. Click here to find out ...

Dave has shown exceptional revenue and EBITDA growth, driven by low expenses and efficient customer acquisition costs. Read ...

With PLTR taking off, there remain other alternatives that investors can buy showing growth potential similar to that of the ...

For example, the MercadoLibre, Inc. (NASDAQ ... returns in the last three years, too. We can see that the MercadoLibre share price is up 95% in the last three years. Meanwhile, EPS is up 162% per ...

Palantir’s surge in stock price shows strong AI growth, but insiders are profiting. Read why PLTR stock may struggle as ...